© 2019 AAVANTI Biotherapeutics & AAVANTI, LLC

Our Story

Our founders, Dr. Corti and Dr. Byrne, have over three decades of research experience focusing on neuromuscular diseases and have spent the latter part of that research focusing on Friedreich's Ataxia.

Throughout their time working with the FA community, Dr. Byrne and Dr. Corti became acquainted with a lot of the amazing people that fight against the disease everyday.  They became a part of that community, doing the rideAtaxia event every year and traveling across the country to meet with patients.

After working on the disease in an academic setting, they decided they wanted to take their research to the next level - gaining support from individual investors and organizations to push forward with new approaches.

 

AavantiBio was founded in 2017 as a way to expand the research done on FA and is driven by Dr. Byrne’s and Dr. Corti’s vision to create the first effective treatment for the disease.